Partial Inhibition, Full Ambition: Regeneron Bets Its Neurology Future On Cemdisiran

 
• By David Wild
  
Regeneron
• Source: Shutterstock: lev radin
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Scaling Cell & Gene Therapy

More from Innovation